NDLI: Mecamylamine but not the α7 receptor antagonist α-bungarotoxin blocks sensitization to the locomotor stimulant effects of nicotine

Content Provider	PubMed Central
Author	Kempsill, F. E. J. Pratt, J. A.
Copyright Year	2000
Abstract	The involvement of α7 receptors in the locomotor stimulant effects of nicotine has been examined by determining the ability of intracerebroventricular (i.c.v.) administration of the α7 receptor antagonist α-bungarotoxin (α-bgt) to modify sensitization to the locomotor activating effects of chronic nicotine. Intracerebroventricular administration of α-bgt (0.02–8 nmoles) produced a dose dependent increase in convulsive behaviour. At doses less than 1.0 nmole, minimal convulsive behaviour occurred but larger doses evoked convulsions in all rats which displayed a more rapid onset time as the dose increased. The binding distribution of α7 receptors 20 min and 3 h following an i.c.v. administration of [125I]-α-bgt (0.02 nmoles) revealed clear binding in the hippocampus, cingulate cortex and hypothalamus which was more intense after 3 h. Rats chronically treated with nicotine (0.4 mg kg−1) and exposed to the locomotor activity apparatus daily acquired an increase in locomotor activity relative to the control group after 3 days of treatment which reached a maximum after 7 days of treatment and was maintained for the 2 week treatment period. Pre-treatment with mecamylamine (1 mg kg−1) prevented the expression of the locomotor stimulant effects of nicotine but pre-treatment with i.c.v. α-bgt (0.02 nmoles) did not affect nicotine-induced changes in locomotor activity. The results of this study support the conclusion that nicotinic receptors of the α4β2 subtype rather than the α7 subtype are important in mediating the expression of the locomotor stimulant effects of nicotine.
Related Links	http://dx.doi.org/10.1038/sj.bjp.0703560
Ending Page	1003
Page Count	7
Starting Page	997
File Format	PDF
ISSN	00071188
Journal	British Journal of Pharmacology
Issue Number	5
Volume Number	131
Language	English
Publisher Date	2000-11-01
Access Restriction	Open
Subject Keyword	Pharmacology Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Pharmacology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Mecamylamine but not the alpha7 receptor antagonist alpha-bungarotoxin blocks sensitization to the locomotor stimulant effects of nicotine.

Characterization of the locomotor stimulant action of nicotine in tolerant rats.

Trace Amine-Associated Receptor 1 Modulates the Locomotor and Sensitization Effects of Nicotine

The α2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats

The cholinergic antagonist α-bungarotoxin also binds and blocks a subset of GABA receptors

Characterization of the locomotor stimulant action of nicotine in tolerant rats.

Cocaine Dose and Self-Administration History, but Not Initial Cocaine Locomotor Responsiveness, Affects Sensitization to the Motivational Effects of Cocaine in Rats

GLUCOSE ATTENUATES IMPAIRMENTS IN MEMORY AND CREB ACTIVATION PRODUCED BY AN α4β2 BUT NOT AN α7 NICOTINIC RECEPTOR ANTAGONIST

Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice.

Mecamylamine but not the α7 receptor antagonist α-bungarotoxin blocks sensitization to the locomotor stimulant effects of nicotine

Similar Documents

Mecamylamine but not the alpha7 receptor antagonist alpha-bungarotoxin blocks sensitization to the locomotor stimulant effects of nicotine.

Characterization of the locomotor stimulant action of nicotine in tolerant rats.

Trace Amine-Associated Receptor 1 Modulates the Locomotor and Sensitization Effects of Nicotine

The α2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats

The cholinergic antagonist α-bungarotoxin also binds and blocks a subset of GABA receptors

Characterization of the locomotor stimulant action of nicotine in tolerant rats.

Cocaine Dose and Self-Administration History, but Not Initial Cocaine Locomotor Responsiveness, Affects Sensitization to the Motivational Effects of Cocaine in Rats

GLUCOSE ATTENUATES IMPAIRMENTS IN MEMORY AND CREB ACTIVATION PRODUCED BY AN α4β2 BUT NOT AN α7 NICOTINIC RECEPTOR ANTAGONIST

Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice.

Mecamylamine but not the α7 receptor antagonist α-bungarotoxin blocks sensitization to the locomotor stimulant effects of nicotine